Oncodesign Services Expands Collaboration with GIP ARRONAX to Advance Targeted Radiotherapy Research
Oncodesign Services strengthens partnership with GIP ARRONAX to secure access to rare radionuclides like astatine-211, supporting preclinical development of next-generation targeted radiotherapy treatments for cancer and other diseases.
Preclinical Research | 14/04/2026 | By News Bureau
Symeres Partners Ambagon Therapeutics to Advance Molecular Glue Research for Cancer Treatment
The collaboration will evaluate novel small-molecule “molecular glues” to target colorectal cancer and other hard-to-treat diseases, aiming to expand next-generation drug discovery approaches.
Preclinical Research | 02/04/2026 | By News Bureau
Moleculin Launches Grant-Funded Study of Annamycin for Pancreatic Cancer at UNC-Chapel Hill
Moleculin has initiated a grant-funded preclinical programme at the University of North Carolina at Chapel Hill to evaluate Annamycin in pancreatic cancer, including its use alongside novel therapeutic agents and modalities. Early studies suggest Annamycin may effectively target key drivers of the disease.
Preclinical Research | 15/11/2025 | By Dineshwori | 160
MetP Pharma Announces Preclinical Research Results of semaglutide Development
MetP Pharma has announced its preclinical research results that strongly support the further development of semaglutide in an oleogel formulation using the BrainDos drug delivery technology.
Preclinical Research | 09/05/2024 | By Aishwarya | 668
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy